Artificial Intelligence could create better outcomes for bowel cancer patients
AI could hold the key to more targeted treatment, according to new research
AI could hold the key to more targeted treatment, according to new research
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
Discover how a brain organoid core facility is applying its glioblastoma model towards developing patient mini-brains
In a ten-year project, a team from the Karl Landsteiner University of Health Sciences has identified a previously unknown role of calcium channels in the formation of synaptic connections
Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant
The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
This partnership aims to offer an accelerated route to market rapid test technologies
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
This week’s Reviewer in the Spotlight, Dr. Ritesh Bhole, discusses communication in science and the value of genuine product reviews, both positive and negative
The monthly safety report will be made public on the European Medicines Agency website
The findings come from the largest study to date to look at inflammatory markers in COVID-19
Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19
With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers
The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails
The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab
Simple, powerful user experience combines with reliability and scalability allowing users to focus on experimental results instead of process
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring